IRLA IRulya Therapeutics Inc. - Common Stock
NASDAQ
$32.96
· of 52w range
· above low
· to high
$25.1352w low
$41.0052w high
your badges
52W Range
$25–$41
Analyst Rating
BUY
Price Target
·
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
IRLA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$32.95
52W Range
$25–$41
IRLA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-9.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-12.31 | $-18.24 | 32.5% | |
| March 31, 2026 | $57.60 | $-52.22 | 210.3% | |
| Dec. 31, 2025 | $-142.00 | $-38.52 | -268.7% | |
| Sept. 30, 2025 | $-50.00 | $-44.15 | -13.3% |
IRLA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
4 30.8%
Strong Buy
8 61.5%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| IRLA | · | · | · | · | · | · |
| ESLA | · | -4.5 | · | · | · | · |
| ACET | · | -0.5 | · | · | · | · |
| CRVO | $73M | · | -58.9% | -673.1% | -104.4% | · |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | · |
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | · |
| CELU | · | -0.3 | -51.0% | · | · | · |
| RNAZ | · | -0.1 | · | · | · | · |
| ABVC | $53M | -5.5 | 234.3% | · | -128.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.